Human Cartilage Homogenates Influence the Crystallization of Monosodium Urate and Inflammatory Response to Monosodium Urate Crystals: A Potential Link Between Osteoarthritis and Gout.
Journal
Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
15
11
2018
accepted:
05
07
2019
pubmed:
13
7
2019
medline:
10
3
2020
entrez:
13
7
2019
Statut:
ppublish
Résumé
Monosodium urate (MSU) crystal deposition and gout flares frequently affect osteoarthritic joints. This study was undertaken to examine the effects of human cartilage homogenates on MSU crystallization and MSU crystal-induced inflammation. Human cartilage homogenates were prepared from macroscopically healthy and macroscopically diseased knee joint samples. Crystallization assays were used to test the effects of cartilage homogenates or individual cartilage factors on MSU crystallization. Changes in urate solubility, crystal nucleation, crystal growth, and total crystal mass were determined. THP-1 cell assays were used to assess cytokine release following culture with MSU crystals grown in the presence or absence of cartilage homogenates or individual proteins. Addition of either 5% or 10% healthy cartilage homogenate increased the total mass of MSU crystals formed and resulted in formation of shorter MSU crystals compared to controls without cartilage homogenate. MSU crystal bows were observed in both the presence and absence of cartilage homogenate; however, bows formed in the presence of cartilage homogenates were significantly shorter than bows formed in their absence. There were no effect differences between macroscopically healthy and macroscopically diseased cartilage homogenates in all assessments. Addition of either type II collagen or albumin also led to the formation of shorter MSU crystals. In THP-1 cell assays, MSU crystals grown with healthy cartilage homogenate increased the release of interleukin-8, whereas MSU crystals grown with type II collagen or albumin had no effect on inflammatory cytokine release. In the presence of elevated urate levels, human cartilage homogenates increase MSU crystal formation and promote the formation of smaller crystals, which have greater inflammatory potential. These processes may contribute to the predilection of osteoarthritic joints to develop gout.
Substances chimiques
Cytokines
0
Uric Acid
268B43MJ25
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2090-2099Informations de copyright
© 2019, American College of Rheumatology.
Références
Faires JS, McCarty DJ Jr. Acute arthritis in man and dog after intrasynovial injection of sodium urate crystals. Lancet 1962;280:682-5.
Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study. Am J Med 1987;82:421-6.
De Miguel E, Puig JG, Castillo C, Peiteado D, Torres RJ, Martín-Mola E. Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study [letter]. Ann Rheum Dis 2012;71:157-8.
Naredo E, Uson J, Jiménez-Palop M, Martínez A, Vicente E, Brito E, et al. Ultrasound-detected musculoskeletal urate crystal deposition: which joints and what findings should be assessed for diagnosing gout? Ann Rheum Dis 2014;73:1522-8.
Roddy E. Revisiting the pathogenesis of podagra: why does gout target the foot? [review]. J Foot Ankle Res 2011;4:13.
Martillo MA, Nazzal L, Crittenden DB. The crystallization of monosodium urate. Curr Rheumatol Rep 2014;16:400.
Roddy E, Doherty M. Gout and osteoarthritis: a pathogenetic link? [editorial]. Joint Bone Spine 2012;79:425-7.
Chhana A, Lee G, Dalbeth N. Factors influencing the crystallization of monosodium urate: a systematic literature review. BMC Musculoskelet Disord 2015;16:296.
Ma CA, Leung YY. Exploring the link between uric acid and osteoarthritis. Front Med (Lausanne) 2017;4:225.
Roddy E, Zhang W, Doherty M. Are joints affected by gout also affected by osteoarthritis? Ann Rheum Dis 2007;66:1374-7.
Grassi W, Meenagh G, Pascual E, Filippucci E. “Crystal clear”-sonographic assessment of gout and calcium pyrophosphate deposition disease. Semin Arthritis Rheum 2006;36:197-202.
Chhana A, Doyle A, Sevao A, Amirapu S, Riordan P, Dray M, et al. Advanced imaging assessment of gout: comparison of dual-energy CT and MRI with anatomical pathology [letter]. Ann Rheum Dis 2018;77:629-30.
Pascual E, Ordóñez S. Orderly arrayed deposit of urate crystals in gout suggest epitaxial formation [letter]. Ann Rheum Dis 1998;57:255.
Pascual E, Addadi L, Andrés M, Sivera F. Mechanisms of crystal formation in gout: a structural approach. Nat Rev Rheumatol 2015;11:725-30.
Katz WA, Schubert M. The interaction of monosodium urate with connective tissue components. J Clin Invest 1970;49:1783-9.
Perricone E, Brandt KD. Enhancement of urate solubility by connective tissue. I. Effect of proteoglycan aggregates and buffer cation. Arthritis Rheum 1978;21:453-60.
Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237-41.
Muehleman C, Li J, Aigner T, Rappoport L, Mattson E, Hirschmugl C, et al. Association between crystals and cartilage degeneration in the ankle. J Rheumatol 2008;35:1108-17.
Eyre DR, Weis MA, Wu JJ. Articular cartilage collagen: an irreplaceable framework? Eur Cell Mater 2006;12:57-63.
Kim HA, Seo YI, Lee J, Jung YO. Detection of anti-type II collagen antibodies in patients with chronic gouty arthritis: findings from a pilot study. J Clin Rheumatol 2016;22:360-3.
Nishimura A, Akahoshi T, Takahashi M, Takagishi K, Itoman M, Kondo H, et al. Attenuation of monosodium urate crystal-induced arthritis in rabbits by a neutralizing antibody against interleukin-8. J Leukoc Biol 1997;62:444-9.
Terkeltaub R, Baird S, Sears P, Santiago R, Boisvert W. The murine homolog of the interleukin-8 receptor CXCR-2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute urate crystal-induced gouty synovitis. Arthritis Rheum 1998;41:900-9.
Terkeltaub R, Zachariae C, Santoro D, Martin J, Peveri P, Matsushima K. Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 1991;34:894-903.
Hachicha M, Naccache PH, McColl SR. Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils: a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis. J Exp Med 1995;182:2019-25.
Dalbeth N, Gracey E, Pool B, Callon K, McQueen FM, Cornish J, et al. Identification of dairy fractions with anti-inflammatory properties in models of acute gout. Ann Rheum Dis 2010;69:766-9.
Netea MG, Nold-Petry CA, Nold MF, Joosten LA, Opitz B, van der Meer JH, et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages. Blood 2009;113:2324-35.
Cronstein BN, Sunkureddi P. Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis. J Clin Rheumatol 2013;19:19-29.
Schumacher HR, Fishbein P, Phelps P, Tse R, Krauser R. Comparison of sodium urate and calcium pyrophosphate crystal phagocytosis by polymorphonuclear leukocytes. Arthritis Rheum 1975;18:783-92.
Paul H, Reginato AJ, Schumacher HR. Morphological characteristics of monosodium urate: a transmission electron microscopic study of intact natural and synthetic crystals. Ann Rheum Dis 1983;42:75-81.
Burt HM, Jackson JK, Rowell J. Calcium pyrophosphate and monosodium urate crystal interactions with neutrophils: effect of crystal size and lipoprotein binding to crystals. J Rheumatol 1989;16:809-17.
Perl-Treves D, Addadi L. A structural approach to pathological crystallizations. Gout: the possible role of albumin in sodium urate crystallization. Proc R Soc Lond B Biol Sci 1988;235:145-59.
Laurent TC. Solubility of sodium urate in the presence of chondroitin-4-sulphate [letter]. Nature 1964;202:1334.
Burt HM, Dutt YC. Growth of monosodium urate monohydrate crystals: effect of cartilage and synovial fluid components on in vitro growth rates. Ann Rheum Dis 1986;45:858-64.
Sophia Fox AJ, Bedi A, Rodeo SA. The basic science of articular cartilage: structure, composition, and function. Sports Health 2009;1:461-8.
Jebens EH, Monk-Jones ME. On the viscosity and pH of synovial fluid and the pH of blood. J Bone Joint Surg Br 1959;41-B:388-400.
Stafford CT, Niedermeier W, Holley HL, Pigman W. Studies on the concentration and intrinsic viscosity of hyaluronic acid in synovial fluids of patients with rheumatic diseases. Ann Rheum Dis 1964;23:152-7.
Schauer C, Janko C, Munoz LE, Zhao Y, Kienhöfer D, Frey B, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med 2014;20:511-7.
Schorn C, Janko C, Krenn V, Zhao Y, Munoz LE, Schett G, et al. Bonding the foe-NETting neutrophils immobilize the pro-inflammatory monosodium urate crystals. Front Immunol 2012;3:376.
Schett G, Schauer C, Hoffmann M, Herrmann M. Why does the gout attack stop? A roadmap for the immune pathogenesis of gout. RMD Open 2015;1:e000046.
Cubillas P, Anderson MW. Synthesis mechanism: crystal growth and nucleation. In: Čejka J, Corma A, Zones S, editors. Zeolites and catalysis, synthesis, reactions and applications. Vol. 1. Weinheim (Germany): WILEY-VCH Verlag GmbH & Co. KGaA; 2010. p. 1-56.
Sunagawa I. Single crystals grown under unconstrained conditions. In: Dhanaraj G, Byrappa K, Prasad V, Dudley M, editors. Springer handbook of crystal growth. Berlin: Springer; 2010. p. 133-56.
Hayes A, Turner IG, Powell KA, Dieppe PA. Crystal aggregates in articular cartilage as observed in the SEM. J Mater Sci Mater Med 1992;3:75-8.
Pascual E, Martínez A, Ordóñez S. Gout: the mechanism of urate crystal nucleation and growth. A hypothesis based in facts. Joint Bone Spine 2013;80:1-4.
Howard RG, Samuels J, Gyftopoulos S, Krasnokutsky S, Leung J, Swearingen CJ, et al. Presence of gout is associated with increased prevalence and severity of knee osteoarthritis: among older men: results of a pilot study. J Clin Rheumatol 2015;21:63-71.
Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Comorbidities in patients with gout prior to and following diagnosis: case-control study. Ann Rheum Dis 2016;75:210-7.
Chhana A, Callon KE, Pool B, Naot D, Gamble GD, Dray M, et al. The effects of monosodium urate monohydrate crystals on chondrocyte viability and function: implications for development of cartilage damage in gout. J Rheumatol 2013;40:2067-74.
Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 2005;174:5016-23.